Medarex, Inc.
Records under this name other than the patents Medarex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,517,903 | Cytotoxic compounds and conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,399,403 | Chemical linkers and conjugates thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,110,194 | CTLA-4 antibody dosage escalation regimens Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,573,999 | CTLA-4 antibody dosage escalation regimens Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,875,278 | Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,461,308 | Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,453,077 | Interferon receptor 1 antibodies and their uses Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,404,820 | Human monoclonal antibodies against Bacillus anthracis protective antigen Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,631,025 | Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,072,090 | Human Anti-B7RP1 Neutralizing Antibodies Formerly held In force · High confidence | In force | High confidence |